Cargando…

HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression

BACKGROUND: HIV-1 envelope diversity remains a significant challenge for the development of an efficacious vaccine. The evolutionary forces that shape the diversity of envelope are incompletely understood. HIV-1 subtype C envelope in particular shows significant differences and unique characteristic...

Descripción completa

Detalles Bibliográficos
Autores principales: Archary, Derseree, Gordon, Michelle L, Green, Taryn N, Coovadia, Hoosen M, Goulder, Philip JR, Ndung'u, Thumbi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992043/
https://www.ncbi.nlm.nih.gov/pubmed/21050445
http://dx.doi.org/10.1186/1742-4690-7-92
_version_ 1782192696883937280
author Archary, Derseree
Gordon, Michelle L
Green, Taryn N
Coovadia, Hoosen M
Goulder, Philip JR
Ndung'u, Thumbi
author_facet Archary, Derseree
Gordon, Michelle L
Green, Taryn N
Coovadia, Hoosen M
Goulder, Philip JR
Ndung'u, Thumbi
author_sort Archary, Derseree
collection PubMed
description BACKGROUND: HIV-1 envelope diversity remains a significant challenge for the development of an efficacious vaccine. The evolutionary forces that shape the diversity of envelope are incompletely understood. HIV-1 subtype C envelope in particular shows significant differences and unique characteristics compared to its subtype B counterpart. Here we applied the single genome sequencing strategy of plasma derived virus from a cohort of therapy naïve chronically infected individuals in order to study diversity, divergence patterns and envelope characteristics across the entire HIV-1 subtype C gp160 in 4 slow progressors and 4 progressors over an average of 19.5 months. RESULTS: Sequence analysis indicated that intra-patient nucleotide diversity within the entire envelope was higher in slow progressors, but did not reach statistical significance (p = 0.07). However, intra-patient nucleotide diversity was significantly higher in slow progressors compared to progressors in the C2 (p = 0.0006), V3 (p = 0.01) and C3 (p = 0.005) regions. Increased amino acid length and fewer potential N-linked glycosylation sites (PNGs) were observed in the V1-V4 in slow progressors compared to progressors (p = 0.009 and p = 0.02 respectively). Similarly, gp41 in the progressors was significantly longer and had fewer PNGs compared to slow progressors (p = 0.02 and p = 0.02 respectively). Positive selection hotspots mapped mainly to V1, C3, V4, C4 and gp41 in slow progressors, whereas hotspots mapped mainly to gp41 in progressors. Signature consensus sequence differences between the groups occurred mainly in gp41. CONCLUSIONS: These data suggest that separate regions of envelope are under differential selective forces, and that envelope evolution differs based on disease course. Differences between slow progressors and progressors may reflect differences in immunological pressure and immune evasion mechanisms. These data also indicate that the pattern of envelope evolution is an important correlate of disease progression in chronic HIV-1 subtype C infection.
format Text
id pubmed-2992043
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29920432010-11-26 HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression Archary, Derseree Gordon, Michelle L Green, Taryn N Coovadia, Hoosen M Goulder, Philip JR Ndung'u, Thumbi Retrovirology Research BACKGROUND: HIV-1 envelope diversity remains a significant challenge for the development of an efficacious vaccine. The evolutionary forces that shape the diversity of envelope are incompletely understood. HIV-1 subtype C envelope in particular shows significant differences and unique characteristics compared to its subtype B counterpart. Here we applied the single genome sequencing strategy of plasma derived virus from a cohort of therapy naïve chronically infected individuals in order to study diversity, divergence patterns and envelope characteristics across the entire HIV-1 subtype C gp160 in 4 slow progressors and 4 progressors over an average of 19.5 months. RESULTS: Sequence analysis indicated that intra-patient nucleotide diversity within the entire envelope was higher in slow progressors, but did not reach statistical significance (p = 0.07). However, intra-patient nucleotide diversity was significantly higher in slow progressors compared to progressors in the C2 (p = 0.0006), V3 (p = 0.01) and C3 (p = 0.005) regions. Increased amino acid length and fewer potential N-linked glycosylation sites (PNGs) were observed in the V1-V4 in slow progressors compared to progressors (p = 0.009 and p = 0.02 respectively). Similarly, gp41 in the progressors was significantly longer and had fewer PNGs compared to slow progressors (p = 0.02 and p = 0.02 respectively). Positive selection hotspots mapped mainly to V1, C3, V4, C4 and gp41 in slow progressors, whereas hotspots mapped mainly to gp41 in progressors. Signature consensus sequence differences between the groups occurred mainly in gp41. CONCLUSIONS: These data suggest that separate regions of envelope are under differential selective forces, and that envelope evolution differs based on disease course. Differences between slow progressors and progressors may reflect differences in immunological pressure and immune evasion mechanisms. These data also indicate that the pattern of envelope evolution is an important correlate of disease progression in chronic HIV-1 subtype C infection. BioMed Central 2010-11-04 /pmc/articles/PMC2992043/ /pubmed/21050445 http://dx.doi.org/10.1186/1742-4690-7-92 Text en Copyright ©2010 Archary et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Archary, Derseree
Gordon, Michelle L
Green, Taryn N
Coovadia, Hoosen M
Goulder, Philip JR
Ndung'u, Thumbi
HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression
title HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression
title_full HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression
title_fullStr HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression
title_full_unstemmed HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression
title_short HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression
title_sort hiv-1 subtype c envelope characteristics associated with divergent rates of chronic disease progression
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992043/
https://www.ncbi.nlm.nih.gov/pubmed/21050445
http://dx.doi.org/10.1186/1742-4690-7-92
work_keys_str_mv AT archaryderseree hiv1subtypecenvelopecharacteristicsassociatedwithdivergentratesofchronicdiseaseprogression
AT gordonmichellel hiv1subtypecenvelopecharacteristicsassociatedwithdivergentratesofchronicdiseaseprogression
AT greentarynn hiv1subtypecenvelopecharacteristicsassociatedwithdivergentratesofchronicdiseaseprogression
AT coovadiahoosenm hiv1subtypecenvelopecharacteristicsassociatedwithdivergentratesofchronicdiseaseprogression
AT goulderphilipjr hiv1subtypecenvelopecharacteristicsassociatedwithdivergentratesofchronicdiseaseprogression
AT ndunguthumbi hiv1subtypecenvelopecharacteristicsassociatedwithdivergentratesofchronicdiseaseprogression